All the shares in the offering (the “Offering”), 3,765,155 shares of DKK 10 nominal value each in Pharmexa A/S (“Pharmexa”), have been subscribed. The Offering attracted great interest among institutional investors, in particular in Scandinavia, the Benelux and the United Kingdom, and shares were therefore allocated to investors on an individual basis.
Pharmexa, The private placement of shares in Pharmexa A/S has been fully subscribed
| Source: Affitech A/S
Attachments
